|
|
|
Volumn 3, Issue 5, 2003, Pages
|
|
Hsp90 molecular chaperone inhibitors: Opportunities and challenges. Preface
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
17 ALLYLAMINOGELDANAMYCIN;
ANTINEOPLASTIC AGENT;
CHAPERONE;
HEAT SHOCK PROTEIN 90;
HEAT SHOCK PROTEIN 90 INHIBITOR;
PROTEIN INHIBITOR;
UNCLASSIFIED DRUG;
CANCER;
CANCER PATIENT;
CANCER RESEARCH;
CANCER RISK;
CHROMATIN STRUCTURE;
CLINICAL TRIAL;
DRUG RESEARCH;
DRUG TARGETING;
EDITORIAL;
HEALTH CARE PERSONNEL;
HUMAN;
ONCOGENE;
PATIENT EDUCATION;
PHYSICIAN;
PROTEIN FUNCTION;
|
|
EID: 0141708704
PISSN: 15680096
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|
